Pan-Lin Capital, formally known as Shanghai Pan-Lin Asset Management Co., is a private equity firm based in Shanghai that specializes in asset management, particularly in equity investments and post-investment activities. The firm is registered with the China Securities Investment Fund Association and has successfully initiated and managed multiple private equity funds, including those focused on healthcare and environmentally-friendly industries. With a strong emphasis on professionalism and value creation, Pan-Lin Capital is supported by a skilled investment management team that possesses complementary expertise and extensive industrial resources. The firm is recognized for its successful exit cases and is positioned among the leaders in the RMB private equity fund market, with a focus on venture investments in healthcare, technology, and education sectors across China.
Danatlas is a pharmaceutical company that develops drugs designed for oncology treatment. It also provides drug research and development in the fields of cancer, inflammation, blood, and metabolic diseases.
Bioyond Tech
Series A in 2024
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Terapark
Series A in 2024
Terapark is a developer and researcher focused on terahertz chip technology, specializing in the production of integrated circuit modules and equipment. The company offers a range of products, including CMOS terahertz integrated circuits, real-time imaging systems, and terahertz sensors. By utilizing standard silicon technology with nanometer precision, Terapark aims to reduce the costs associated with terahertz technology. This approach supports the wider adoption of terahertz applications in various sectors, such as intelligent manufacturing industry inspection, intelligent transportation, energy Internet of Things monitoring, environmental monitoring, and health monitoring.
Zhixin Haozheng
Seed Round in 2024
Zhixin Haozheng is an inventor of regenerating islet technology. The company focuses on in vitro regeneration of human tissues and organs, with the major pipeline consisting of regenerative islets that can be implanted to cure diabetes.
Caprico Biotechnologies
Seed Round in 2024
Caprico Biotechnologies is a biotechnology company focused on developing and providing flow cytometry reagents and services for various research purposes, including basic and clinical research, as well as clinical diagnostics. The company specializes in immunophenotyping and offers a range of products, including custom services and a catalog of analyte-specific reagents. Caprico Biotechnologies is particularly noted for its expertise in T-cell clonality-specific products and non-human primate primary antibodies. In addition to these offerings, the company provides assay design and development services and manufactures and conjugates antibodies specifically for flow cytometry applications. Through its comprehensive product and service portfolio, Caprico Biotechnologies aims to enhance operational efficiency for researchers in the field.
Fibresound Technology
Seed Round in 2023
Fibresound Technology is a chip development company that specializes in the R&D and design of piezoelectric MEMS microphone chips.
Shitong Microelectronics
Seed Round in 2023
Shitong Microelectronics specializes in the design and development of machine vision-detecting sensors, particularly 3D sensors. It seeks to create 3D sensors with high precision, low power consumption, and competitive prices.
LeadBio Tech
Series A in 2023
LeadBio Tech is a biotechnology company focused on creating bioartificial blood vessel medical devices. The company specializes in tissue engineering and tissue regeneration solutions aimed at replacing and repairing human tissues and organs. LeadBio Tech develops degradable bioartificial blood vessels utilizing innovative skeleton immune wrapping technology. These products are primarily designed for use in arteriovenous graft surgeries, offering advanced artificial vessel solutions to enhance patient care and outcomes.
O-Cubes
Series A in 2023
O-Cubes focus on micro chip research and development in wireless communication field.
dina dollar liter
Seed Round in 2023
dina dollar litre is a nucleic acid nanocarrier technology provider who focuses on the development of nucleic acid nanocarrier technology.
Levinthal
Angel Round in 2023
Levinthal operates as an AI-driven protein design platform, specializing in the development of artificial intelligence algorithms and experimental process technology. The company focuses on improving the industrial production of biological molecules and microbes, catering to sectors such as synthetic biology, food, feed, cosmetics, and environmental protection. By leveraging its expertise, Levinthal aims to enhance the stability and efficiency of enzymes, thereby providing valuable technical services that support advancements in food safety and medical care.
Easy Logic
Series A in 2023
Easy Logic is a developer of electronic design automation tools.
Jinfang Pharmaceutical
Series C in 2023
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
Tingke Biotechnology
Series A in 2023
Tingke Biotechnology develops microfluidic products for industry partners. They offer products that include vitro diagnostics, organ chips, nanomedicine, material synthesis, food safety, and environmental protection testing.
Zhishan Weixin Biotechnology
Series A in 2023
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
Ruiyun Cold Chain
Seed Round in 2022
Ruiyun Cold Chain is a logistics service platform in China that utilizes innovative domestic technology to offer comprehensive cold chain transportation solutions. The company provides digital, end-to-end integration services designed to optimize operational efficiency for its customers. Through its unique platform, which includes Lengyunbao—an online trading platform for carriers—and a dual-end app, Ruiyun Cold Chain facilitates smooth transactions, deliveries, settlements, and tax collection. By fostering collaboration within the cold chain network, the company effectively reduces logistics costs for cargo owners by 10% to 15%, linking industry resources with customer demand through digital intelligence.
Terapark
Seed Round in 2022
Terapark is a developer and researcher focused on terahertz chip technology, specializing in the production of integrated circuit modules and equipment. The company offers a range of products, including CMOS terahertz integrated circuits, real-time imaging systems, and terahertz sensors. By utilizing standard silicon technology with nanometer precision, Terapark aims to reduce the costs associated with terahertz technology. This approach supports the wider adoption of terahertz applications in various sectors, such as intelligent manufacturing industry inspection, intelligent transportation, energy Internet of Things monitoring, environmental monitoring, and health monitoring.
Ribo Biotech
Series E in 2022
Ribo Biotech develops RNA interference drugs and is committed to the research and development of small nucleic acid drugs.
Terapark
Seed Round in 2022
Terapark is a developer and researcher focused on terahertz chip technology, specializing in the production of integrated circuit modules and equipment. The company offers a range of products, including CMOS terahertz integrated circuits, real-time imaging systems, and terahertz sensors. By utilizing standard silicon technology with nanometer precision, Terapark aims to reduce the costs associated with terahertz technology. This approach supports the wider adoption of terahertz applications in various sectors, such as intelligent manufacturing industry inspection, intelligent transportation, energy Internet of Things monitoring, environmental monitoring, and health monitoring.
NuProbe
Series B in 2022
NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.
Yueer Gene
Series B in 2022
Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.
PPIO
Series A in 2022
PPIO is a distributed cloud computing initiative founded by Bill Yao and Wayne Wang in 2018, aimed at creating a decentralized cloud service platform. The company focuses on harnessing global computing resources to serve various edge computing scenarios that require low latency, high bandwidth, and enhanced reliability and security. Leveraging a combination of big data, cloud-native, and distributed computing technologies, PPIO operates micro data centers in over 1,000 cities and regions across China. It provides a range of services including eBareMetal, eContainer, content delivery networks (CDN), audio and video live streaming and transcoding, application performance monitoring, AI computing reasoning, and cloud game rendering. PPIO has established itself as a major provider of distributed cloud services for leading audio and video internet companies, cloud computing firms, and innovative startups both domestically and internationally.
GenFleet Therapeutics
Series C in 2021
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative molecular pharmaceuticals and antibody drugs that target various cancer systems. GenFleet's work involves developing signal transduction regulators, tumor microenvironment modulators, and transcription factors, among other therapeutic agents. The company's mission is to provide effective medical solutions that can reactivate tumor-specific immune responses and enhance the body's own immune system in combating cancer. With a commitment to advancing cancer therapies, GenFleet serves both domestic and international markets.
Xiaoxiang Zhihe
Series A in 2021
Xiaoxiang Zhihe is a packaging innovation Internet service platform from design to production. Xiaoxiang Zhihe focuses on professional packaging innovation, providing brands with product strategy, packaging creative design and structure development, brand color consistency management, sample production, packaging and printing production management and other services. Xiaoxiang Zhihe is committed to recreating an industrial Internet platform in China’s printing and packaging industry to centralize and online decentralized production capacity. At present, the company’s self-developed packaging and printing supply chain management platform connects more than 40 excellent design institutions and The 200 member factories provide a more convenient design innovation, flexible manufacturing, high-efficiency and high-quality intelligent supply chain service platform for the packaging upgrade of Chinese brands.
PPIO
Series A in 2021
PPIO is a distributed cloud computing initiative founded by Bill Yao and Wayne Wang in 2018, aimed at creating a decentralized cloud service platform. The company focuses on harnessing global computing resources to serve various edge computing scenarios that require low latency, high bandwidth, and enhanced reliability and security. Leveraging a combination of big data, cloud-native, and distributed computing technologies, PPIO operates micro data centers in over 1,000 cities and regions across China. It provides a range of services including eBareMetal, eContainer, content delivery networks (CDN), audio and video live streaming and transcoding, application performance monitoring, AI computing reasoning, and cloud game rendering. PPIO has established itself as a major provider of distributed cloud services for leading audio and video internet companies, cloud computing firms, and innovative startups both domestically and internationally.
KingstronBio
Series C in 2021
KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.
Chuantu Microelectronics
Series B in 2021
Shanghai Chuantu Microelectronics Co., Ltd. specializes in the design of semiconductor chips, focusing on radiofrequency analog chips and micromodules, along with related solutions. Established in 2016, the company is headquartered in Shanghai, China. Through its innovative chip designs, Chuantu Microelectronics aims to meet the growing demands of various industries that require advanced electronic components.
3N Tech
Series A in 2021
3N Tech is a manufacturer specializing in contact lens care products that prioritize eye health. The company utilizes advanced biotechnology, specifically biomedical electrophoresis deproteinization technology, to create a range of innovative solutions for contact lens users. Their product line includes items designed for protein precipitation removal, sterilization, antibacterial treatment, and safe storage of contact lenses. By focusing on these aspects, 3N Tech aims to provide effective safety protection and promote healthy eye care for individuals who wear contact lenses.
Ruiyun Cold Chain
Angel Round in 2021
Ruiyun Cold Chain is a logistics service platform in China that utilizes innovative domestic technology to offer comprehensive cold chain transportation solutions. The company provides digital, end-to-end integration services designed to optimize operational efficiency for its customers. Through its unique platform, which includes Lengyunbao—an online trading platform for carriers—and a dual-end app, Ruiyun Cold Chain facilitates smooth transactions, deliveries, settlements, and tax collection. By fostering collaboration within the cold chain network, the company effectively reduces logistics costs for cargo owners by 10% to 15%, linking industry resources with customer demand through digital intelligence.
Percipio.XYZ
Series B in 2021
Shanghai Percipio Information Technology Co., Ltd. specializes in developing 3D machine vision technology, offering integrated hardware and software solutions for various industries. Founded in 2015 and based in Shanghai, the company manufactures 3D-depth cameras along with supporting algorithms that cater to sectors such as manufacturing, logistics, smart security, and automotive. Their technology is utilized for applications including industrial automation, quality control, visual SLAM, and interactive machine systems. Percipio’s products enable clients to analyze product flows and enhance operational efficiency, making them a valuable partner for businesses seeking to implement advanced visual solutions in their operations.
NuProbe
Series B in 2021
NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.
GenFleet Therapeutics
Venture Round in 2021
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative molecular pharmaceuticals and antibody drugs that target various cancer systems. GenFleet's work involves developing signal transduction regulators, tumor microenvironment modulators, and transcription factors, among other therapeutic agents. The company's mission is to provide effective medical solutions that can reactivate tumor-specific immune responses and enhance the body's own immune system in combating cancer. With a commitment to advancing cancer therapies, GenFleet serves both domestic and international markets.
KingstronBio
Venture Round in 2020
KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.
Virogin Biotech
Series C in 2020
Virogin Biotech Ltd., founded in 2015 and based in Vancouver, Canada, focuses on developing innovative oncolytic virus therapeutics aimed at treating cancer. Utilizing its proprietary Synerlytic™ technical platform, the company enhances cancer treatment by harnessing immunological principles to create therapies that stimulate and amplify the body's immune response against tumors. Virogin's approach is centered on leveraging multiple payload expressions to generate a robust and transient antiviral immune response, thereby improving systemic antitumor immunity. With its commitment to advancing immunotherapy, Virogin aims to establish itself as a leader in the field of immuno-oncology.
Bichen Pharmaceutical
Series A in 2020
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
Jinfang Pharmaceutical
Series B in 2020
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
GenFleet Therapeutics
Series B in 2020
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative molecular pharmaceuticals and antibody drugs that target various cancer systems. GenFleet's work involves developing signal transduction regulators, tumor microenvironment modulators, and transcription factors, among other therapeutic agents. The company's mission is to provide effective medical solutions that can reactivate tumor-specific immune responses and enhance the body's own immune system in combating cancer. With a commitment to advancing cancer therapies, GenFleet serves both domestic and international markets.
Yesmro
Series A in 2020
Yesmro, also known as Yimai Gongpin, is a retail company focused on supplying automation parts and industrial supplies to small and medium-sized enterprises. The company offers an extensive range of products, including electrical accessories, wires and cables, and industrial control components, catering specifically to the needs of businesses involved in technological development. By leveraging technology and data-driven approaches, Yesmro aims to deliver affordable and convenient solutions, enabling small enterprises to easily access the industrial products they require for their operations. The company's commitment to providing long-tail services ensures that even niche market needs are met efficiently and cost-effectively.
Percipio.XYZ
Series A in 2020
Shanghai Percipio Information Technology Co., Ltd. specializes in developing 3D machine vision technology, offering integrated hardware and software solutions for various industries. Founded in 2015 and based in Shanghai, the company manufactures 3D-depth cameras along with supporting algorithms that cater to sectors such as manufacturing, logistics, smart security, and automotive. Their technology is utilized for applications including industrial automation, quality control, visual SLAM, and interactive machine systems. Percipio’s products enable clients to analyze product flows and enhance operational efficiency, making them a valuable partner for businesses seeking to implement advanced visual solutions in their operations.
Suzhou Ribo Life Science
Series C in 2019
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Thorough Future
Seed Round in 2019
Thorough Future specializes in the integration of advanced technology within the medical sector, focusing on enhancing diagnostic services in clinical medicine. The company leverages artificial intelligence and big data to offer intelligent diagnosis and predictive services for pathology images. This innovative approach aims to improve diagnostic accuracy and efficiency, particularly for cancer patients, by providing personalized treatment recommendations. Through its commitment to integrating cutting-edge technology into healthcare, Thorough Future seeks to transform the way medical diagnoses are conducted and treatments are tailored.
Yesmro
Series A in 2019
Yesmro, also known as Yimai Gongpin, is a retail company focused on supplying automation parts and industrial supplies to small and medium-sized enterprises. The company offers an extensive range of products, including electrical accessories, wires and cables, and industrial control components, catering specifically to the needs of businesses involved in technological development. By leveraging technology and data-driven approaches, Yesmro aims to deliver affordable and convenient solutions, enabling small enterprises to easily access the industrial products they require for their operations. The company's commitment to providing long-tail services ensures that even niche market needs are met efficiently and cost-effectively.
Antekang Cheng
Seed Round in 2019
Antai Kangcheng is a research and development company specializing in tumor electric field treatment technology, primarily aimed at addressing glioblastoma multiforme. The firm focuses on creating innovative treatment methods for tumors, as well as technologies for central nervous system injury repair and neurorehabilitation. Antai Kangcheng has developed a precise treatment planning system that utilizes biophysical models and multimodal imaging systems, enabling the visualization of intracranial field strength. This capability allows for effective management of electro-nodes to track tumors within the electric field, facilitating personalized treatment approaches for cancer patients, particularly in the Chinese market. The company's commitment to improving treatment affordability and effectiveness underscores its dedication to advancing cancer care.
Happy Cycle
Seed Round in 2019
Happy Cycle is a fitness studio brand based on the dynamic cycling category. Based on the concept of “Make Fitness Having a Better Life”, Happy Cycle offers immersive fitness scenes and dynamic cycling verticals with music, games, video, social and other entertainment elements, allowing users to complete their fitness in the entertainment experience.
Qinheli Biomedical
Seed Round in 2019
Qinheli Biomedical is a tumor micro-environment-responsive drug developer dedicated to the development and production of low-toxic and highly effective patented anti-cancer drugs.
Chuantu Microelectronics
Series A in 2019
Shanghai Chuantu Microelectronics Co., Ltd. specializes in the design of semiconductor chips, focusing on radiofrequency analog chips and micromodules, along with related solutions. Established in 2016, the company is headquartered in Shanghai, China. Through its innovative chip designs, Chuantu Microelectronics aims to meet the growing demands of various industries that require advanced electronic components.
LangRui Medical
Seed Round in 2019
LangRui Medical is a cardiac remote diagnosis service provider, which provides users with cardiac medical remote diagnosis, data analysis, data storage and other services, and uses its own network platform to move the ECG inspection project of the networked top three hospitals to the primary medical institutions. Hospital medical informatization level.
Apollomics
Series B in 2019
Apollomics, Inc. is an emerging life sciences company based in Foster City, California, focused on developing innovative oncology therapies aimed at targeting the growth and proliferation of cancer cells. Founded in 2016, the company’s pipeline includes several development-stage assets, such as CBT-101, an oral agent that targets the epithelial to mesenchymal transition pathway associated with various tumors, and CBT-102, which inhibits the MAP Kinase pathway and angiogenesis through its effects on specific receptors. Additionally, Apollomics is advancing monoclonal antibodies CBT-501 and CBT-502, which target the PD-1 and PDL-1 membrane receptors, respectively, to enhance the immune response against cancer. By combining immune-based strategies with targeted therapies, Apollomics aims to develop novel treatments that can effectively combat cancer.
Yesmro
Seed Round in 2018
Yesmro, also known as Yimai Gongpin, is a retail company focused on supplying automation parts and industrial supplies to small and medium-sized enterprises. The company offers an extensive range of products, including electrical accessories, wires and cables, and industrial control components, catering specifically to the needs of businesses involved in technological development. By leveraging technology and data-driven approaches, Yesmro aims to deliver affordable and convenient solutions, enabling small enterprises to easily access the industrial products they require for their operations. The company's commitment to providing long-tail services ensures that even niche market needs are met efficiently and cost-effectively.
Gongguizhijia
Series A in 2018
Gongguizhijia is a commercial vehicle technology service platform based in Shanghai, China, founded in 2014. The company specializes in providing comprehensive support services for after-sales maintenance at commercial vehicle service stations, catering to both these stations and aftermarket customers. Their offerings include full vehicle repair, advanced calibration, and intelligent data management, which encompasses multi-protocol concurrency, data stream grouping, and data stream unit conversion. Through these services, Gongguizhijia aims to enhance the efficiency and effectiveness of after-sales support in the commercial vehicle sector.
Iris Integrated Retail Information Solution
Series A in 2018
Iris Integrated Retail Information Solution is a retail IT solution provider based in Shanghai, China. The company specializes in offering a range of enterprise services that include IT retail data operations, business intelligence solutions, and cloud-based management systems. Iris provides the Iris BI 1.2 Pro series, an integrated application designed for businesses engaged in retail data processing across various industries. Additionally, the company develops mobile applications and offers services in mobile IT products, including eBook production and app development. Iris also provides IT consulting and training services to support businesses in optimizing their operations and leveraging technology effectively.
AOSSCI
Series A in 2018
AOSSCI specializes in the development of unmanned aerial vehicles (UAV) and associated systems, including flight control systems and ground stations. The company offers a range of products, such as high-performance all-electric drones and integrated flight simulation platforms designed for various industrial applications. AOSSCI's UAV solutions are utilized in sectors such as land surveying, public safety, power line inspection, resource exploration, and environmental protection, both domestically and internationally. By focusing on advanced technology, AOSSCI aims to enhance operational capabilities across industries including oil exploration, landscape mapping, and smart urban management.
Chuantu Microelectronics
Seed Round in 2018
Shanghai Chuantu Microelectronics Co., Ltd. specializes in the design of semiconductor chips, focusing on radiofrequency analog chips and micromodules, along with related solutions. Established in 2016, the company is headquartered in Shanghai, China. Through its innovative chip designs, Chuantu Microelectronics aims to meet the growing demands of various industries that require advanced electronic components.
XGimi
Corporate Round in 2018
XGimi is a Chinese company based in Chengdu that specializes in the design and manufacture of multi-functional projectors and laser TVs. Founded in 2012, XGimi focuses on creating high-performance, high-definition projectors that incorporate an Android operating system and offer three-dimensional viewing capabilities. The company aims to provide affordable giant-screen projection solutions to consumers worldwide, emphasizing innovation and quality in its product offerings.
YCloset
Series B in 2017
YCloset was an online platform based in Beijing that offered a clothing rental and shopping service specifically for women. Founded in 2015, the platform allowed users to enroll for a monthly fee, enabling them to rent clothes and accessories without additional charges for individual items. YCloset operated in approximately 40 cities across China, including major urban centers like Beijing, Shanghai, Guangzhou, and Shenzhen. The company partnered with over a hundred fashion brands to provide a diverse selection of rental options, helping women stay current with fashion trends without the need to purchase new clothing. However, YCloset announced its closure, ceasing operations by August 15, 2021.
Suzhou Ribo Life Science
Series B in 2017
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Percans Oncology
Series B in 2017
Percans Oncology is a research company focused on tumor treatment, offering individualized treatment plans designed to effectively address cancer. The company specializes in developing cancer-specific drug products, particularly in the areas of synthetic lethality and immunotherapy. Their services include cross-indication drug combination solutions, in vitro susceptibility testing, and a tumor cell drug sensitivity detection kit. By utilizing these innovative approaches, Percans Oncology aims to provide tailored therapies that can extend and save the lives of cancer patients.
Passiontec
Series A in 2016
Passiontec is a community e-commerce platform for life services. The company offers services including catering, food delivery, taxi-hailing, shared bicycles, hotel travel, movies, leisure activities, and entertainment, and it has apps that are well-known to customers like Meituan, Dianping, and Meituan Waimai. It is a social company that aims to develop a smart city and a better way of life by working closely with government and party agencies, academic institutions, the general public, public welfare organizations, and ecological partners.
Dream
Series B in 2012
Dream is a company that offers game creation services with the goal of creating a variety of web games, social games, and mobile Internet games. Clients can access a variety of online games cause of the company's gaming development services, which include numerous cross-platform gaming facilities that are also exported to other markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.